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Hiding telomerase from chromatin
 
elomerase helps cancerous cells survive by extending 
telomeres at the end of chromosomes. According to new 
results from Judy Wong, Leonard Kusdra, and Kathleen 
Collins (University of California, Berkeley, CA), cancer cells 
recruit additional telomerase by setting it free from its sub-
nuclear storage depot.
Telomerase is activated upon association of two subunits, 
telomerase reverse transcriptase (TERT) and telomerase RNA, 
into a ribonucleoprotein (RNP) complex. Collins’ group 
tracked the active form in normal and cancerous cells by 
expressing GFP-labeled TERT in limiting amounts that would 
assemble rapidly with the RNP. This technique revealed that 
telomerase differed mainly in its location. “A normal cell 
hides telomerase, by tying it to the nucleolus,” says Collins. 
In these cells, telomerase was concentrated in the nucleoplasm 
during S phase, when its activity is required to maintain 
chromosome ends. In contrast, transformed cells released all 
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Semaphorins—not just for axons
 
n axon guidance factor can work with growth factor 
receptors to trigger invasive growth, according to a 
recent article by Silvia Giordano, Paolo Comoglio, and 
colleagues (Institute for Cancer Research, University of 
Torino, Torino, Italy).
The guidance cues are semaphorins, soluble and cell 
surface molecules that have homology to Met, a scatter 
factor (SF) receptor tyrosine kinase. Met and semaphorins 
also share homology with the extracellular domain of 
semaphorin receptors, known as plexins. Because plexins 
and semaphorins are expressed outside the nervous 
system, Giordano et al. examined what function they 
might control in other tissues.
They found that ligand stimulation 
of a plexin in epithelial cells caused 
invasive growth, including scattering 
and anchorage-independent growth. 
Met is the only kinase known to trigger 
invasive growth and, as expected, 
without Met, this plexin-stimulated 
growth was blocked. Epithelial cells 
seem primed for crosstalk between 
the two receptors, as Met and plexin 
were in a preformed complex, 
mediated by their conserved domains. 
SF and semaphorins in combination 
produced a stronger response than 
either alone. “These two modalities of 
activation can cooperate for certain 
biological responses but not for 
others, and this could be a way to 
fine tune responses such as invasion, 
without interfering with growth,” says Giordano. 
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Semaphorins (mid-
dle) and SF (bot-
tom) both induce 
invasive growth.
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Promiscuous Ras turns 
on the wrong partner
 
cancerous form of Ras is dangerous because it intrudes on 
pathways where it is normally unwelcome, according to results 
from David Prober and Bruce Edgar (Fred Hutchinson Cancer 
Research Center, Seattle, WA).
The small GTPase Ras is stimulated by 
epidermal growth factor receptors in flies 
and vertebrates. Activated Ras initiates multiple 
cellular responses, including cell growth and 
differentiation. The importance of downstream 
effectors such as PI3K and Myc for each 
response has not been firmly determined, 
in part because their involvement varies 
depending on the cell culture system used.
Prober and Edgar put some of this 
controversy to rest by examining how Ras 
can control cell growth in vivo. In the 
developing fly wing, both Myc and PI3K 
were up-regulated in clones of cells expressing 
an activated form of Ras, which increases 
cell size and growth rates. Although this 
form of Ras increased both Myc and PI3K, these pathways were 
activated independently of each other.
The activated Ras is one commonly found in mammalian tumors. 
But in normal cells, although wild-type Ras was required for Myc 
signaling, it had no effect on PI3K activity. Thus, says Edgar, 
“oncogenic Ras seems to short circuit endogenous signals,” by impinging 
on the PI3K pathway. The combined effects of Myc (which turns 
on transcription of translational machinery) and PI3K (which may 
increase nutrient import into cells) make oncogenic Ras a superpotent 
variant for increasing growth.
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Activation of wild-type 
Ras (arrows) increases 
Myc (red) but not PI3K 
(green) signaling.
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of their telomerase from the nucleoli, 
regardless of cell cycle phase.
The proteins that control telomerase 
localization are not yet known, but the 
ability of transformed cells to bypass 
this regulation may give them a twofold 
advantage. First, telomerase would 
be more effective on an established 
telomere because more of it is released 
from nucleolar stores. Additionally, 
continuous release of telomerase may 
support the high genomic instability 
of cancerous cells: adding telomeres 
to broken chromosome ends might 
allow normal segregation of rearranged 
chromosomes that might otherwise 
arrest the cell cycle. 
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Telomerase (green) 
escapes the nucleoli 
(red) in cancer cells 
(bottom).
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